Metabolic Syndrome and Risk of Gastrointestinal Cancers: An Investigation Using Large-scale Molecular Data

BACKGROUND & AIMS: Gastrointestinal cancer risk is influenced by the presence of metabolic syndrome (MetS). However, previous epidemiologic studies lacked full serological biomarker data for the classification of MetS, and the interaction of MetS with germline cancer risk variants is unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothwell, Joseph A., Jenab, Mazda, Karimi, Mojgan, Truong, Thérèse, Mahamat-Saleh, Yahya, Ferrari, Pietro, Dashti, S. Ghazaleh, Kühn, Tilman, Cross, Amanda J., Severi, Gianluca, Gunter, Marc J., Murphy, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders for the American Gastroenterological Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117007/
https://www.ncbi.nlm.nih.gov/pubmed/34687971
http://dx.doi.org/10.1016/j.cgh.2021.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117007/
https://www.ncbi.nlm.nih.gov/pubmed/34687971
http://dx.doi.org/10.1016/j.cgh.2021.10.016

Ejemplares similares